South Korea secures 30 million Pfizer doses for 2022 booster campaign
South Korea has signed a contract with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine for use in 2022 as part of a plan to administer 50 million booster shots.